Aspirin and Extended-Release Dipyridamole NDC 65162-596

NDC codes

FDA NDC Directory

Product NDC (as listed)65162-596Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65162-0596Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65162-596-06	65162059606	60 CAPSULE in 1 BOTTLE (65162-596-06)Marketed from Mar 28, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Aspirin and Extended-Release Dipyridamole
Generic name (nonproprietary): aspirin and extended-release dipyridamole
Active ingredients: Aspirin — 25 mg/1Dipyridamole — 200 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Amneal Pharmaceuticals LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206392
Marketing start: Mar 28, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)Decreased Platelet Aggregation (Physiologic effect)Decreased Platelet Aggregation (Physiologic effect)Decreased Prostaglandin Production (Physiologic effect)
Identifiers: Product ID 65162-596_bf81f508-2def-4916-a2f1-0f73f473be3fSPL ID bf81f508-2def-4916-a2f1-0f73f473be3fSPL set ID 369cb8a3-e1e4-4150-859d-4f788436ddcaRxCUI 259081UNII R16CO5Y76E, 64ALC7F90CUPC 0365162596069
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465162059606 followed by a unit qualifier and the quantity

Package 65162-0596-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 23, 2021.

Indications (excerpt from the label)

Aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Aspirin and extended-release dipyridamole capsules are a combination of aspirin and dipyridamole, antiplatelet agents, indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 206392

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206392
Product	Strength	Form · route	Labeler	Product NDC
Aspirin and Extended-Release Dipyridamole	Aspirin 25 mg/1; Dipyridamole 200 mg/1	CapsuleOral	AvKARE	42291-116